PDGFRB Cancer Research Results

PDGFRB, Platelet-derived growth factor receptor beta: Click to Expand ⟱
Source:
Type:

PDGFRB is a true druggable receptor tyrosine kinase with relevance to tumor stroma, angiogenesis, pericytes, fibrosis, BBB integrity, and AD vascular dysfunction.

Field Suggested Entry
Target PDGFRB / PDGFR-β
Full Name Platelet-derived growth factor receptor beta
Target Class Receptor tyrosine kinase
Main Ligands PDGF-BB, PDGF-DD
Primary Biology Pericyte recruitment, vascular maturation, fibroblast activation, stromal remodeling, cell migration, proliferation, BBB maintenance
Cancer Relevance High: tumor stroma, angiogenesis, pericytes, CAFs, invasion, metastasis, therapy resistance
AD Relevance Medium-high: brain pericytes, blood-brain barrier integrity, neurovascular dysfunction, soluble PDGFRβ as a pericyte injury marker
Therapeutic Direction Context-dependent. In cancer, inhibition or stromal normalization may be useful. In AD, preservation/restoration of PDGFRβ signaling is likely protective.


Scientific Papers found: Click to Expand⟱
6466- 1,8-Cin,    Transcriptome Analysis Reveals the Anti-Tumor Mechanism of Eucalyptol Treatment on Neuroblastoma Cell Line SH-SY5Y
- in-vitro, neuroblastoma, SH-SY5Y
AntiTum↑, TumCCA↑, PDGFRB↓, Myc↓, LEF1↓, BAD↑, APC↑, TBX3↑,
7393- Amla,    Emblica officinalis extract induces autophagy and inhibits human ovarian cancer cell proliferation, angiogenesis, growth of mouse xenograft tumors
- vitro+vivo, Ovarian, OVCAR-3 - in-vitro, Ovarian, SW626
TumCP↓, Beclin-1/ATG6↑, LC3B-II↑, Hif1a↓, Dose↝, TumAuto↑, angioG↓, COL4A3↓, CXCL6/GCP-2↓, TYMP/ECGF1↓, IL1β↓, PDGFRB↓, ChemoSen↑, Dose↝,
7999- itraC,    Itraconazole-Induced Inhibition on Human Esophageal Cancer Cell Growth Requires AMPK Activation
- vitro+vivo, ESCC, NA
AMPK↑, EGFR↓, PDGFRA↓, PDGFRB↓, Akt↓, TumCG↓,

Showing Research Papers: 1 to 3 of 3

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

COL4A3↓, 1,   CXCL6/GCP-2↓, 1,   TYMP/ECGF1↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

AMPK↑, 1,  

Cell Death(tgid=5) ⓘ

Akt↓, 1,   BAD↑, 1,   Myc↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↑, 1,   LC3B-II↑, 1,   TumAuto↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

TBX3↑, 1,   TumCCA↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

PDGFRA↓, 1,   PDGFRB↓, 3,   TumCG↓, 1,  

Migration(tgid=13) ⓘ

APC↑, 1,   LEF1↓, 1,   TumCP↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   EGFR↓, 1,   Hif1a↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

IL1β↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ChemoSen↑, 1,   Dose↝, 2,  

Clinical Biomarkers(tgid=22) ⓘ

EGFR↓, 1,   Myc↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiTum↑, 1,  
Total Targets: 27

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: PDGFRB, Platelet-derived growth factor receptor beta
1 1,8-Cineole
1 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
1 itraconazole
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:0  prod#:%  Target#:1495  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

 

Home Page